PACKAGE LEAFLET: INFORMATION FOR THE USER
Page 1 of 6 Package leaflet: Information for the user Zinforo ® 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil
Information, User, Solutions, Leaflet, Packages, Concentrate, Infusion, Package leaflet, Information for the user, Concentrate for solution for infusion
Download PACKAGE LEAFLET: INFORMATION FOR THE USER
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
Package leaflet: Information for the user Clexane …
www.medicines.org.uk1 Package leaflet: Information for the user. Clexane® Syringes 2,000 IU (20 mg)/0.2 ml solution for injection in pre-filled syringes . Clexane® Syringes 4,000 IU (40 mg)/0.4 ml solution for injection in pre-filled syringes
small pharma code may appear on the front / back …
www.medicines.org.ukKeep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the blister and carton after EXP.
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1. Package Leaflet 1 PACKAGE LEAFLET: INFORMATION FOR THE USER CALCEOS 500mg/400IU CHEWABLE TABLETS …
Information, User, Leaflet, Packages, Package leaflet, Information for the user
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1 Package Leaflet 1 Package leaflet: Information for the patient Laxido Orange, powder for oral solution. Read all of this leaflet carefully before you start taking this medicine because it contains
Information, User, Leaflet, Packages, Package leaflet, Information for the user, Information for the
Package leaflet: Information for the user - Medicines
www.medicines.org.ukPage 1 of 8 v019_0 Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack.
Package leaflet: Information for the user …
www.medicines.org.ukRead all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet.
PFIZER Package leaflet: Information for the patient …
www.medicines.org.ukPage 1 of 20 PFIZER Package leaflet: Information for the patient Depo-Provera® 150 mg/ml Sterile Suspension for Injection Medroxyprogesterone acetate Please read all of this leaflet carefully before you start using this medicine because it
Information, Leaflet, Packages, Pfizer, Information for the, Depo, Pfizer package leaflet
SAYANA PRESS 104 mg/0.65 ml suspension for …
www.medicines.org.ukPage 1 of 15 Package leaflet: Information for the user SAYANA PRESS® 104 mg/0.65 ml suspension for injection medroxyprogesterone acetate Single-dose container ...
Single, Dose, Injection, Acetate, Suspension, Medroxyprogesterone, Suspension for injection medroxyprogesterone acetate single dose
PACKAGE LEAFLET: INFORMATION FOR THE USER …
www.medicines.org.ukPACKAGE LEAFLET: INFORMATION FOR THE USER Bisoprolol 2.5 mg Film-coated Tablet Bisoprolol 5 mg Film-coated Tablet Bisoprolol 10 mg Film-coated Tablet
Patient Information Leaflet - Medicines
www.medicines.org.ukPage 2 of 10 Patient Information Leaflet Salazopyrin® EN-tabs 500 mg enteric-coated tablets sulfasalazine In this leaflet: 1. What Salazopyrin EN …
Related documents
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euFasturtec 1.5 mg/ml powder and solvent for concentrate for solution for infusion.
Product, Solutions, Concentrate, Infusion, Concentrate for solution for infusion
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eu4 The recommended dose of Avastin when used in addition to erlotinib is 15 mg/kg of body weight given once every 3 weeks as an intravenous infusion.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzPage 1 of 4 NEW ZEALAND DATA SHEET 1. PRODUCT NAME GLYCOPHOS 306.1 mg/mL Infusion, concentrate 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Zometa data sheet - Medsafe Home Page
www.medsafe.govt.nz1 . NEW ZEALAND DATA SHEET . 1 PRODUCT NAME ZOMETA® 4 mg/5 mL Liquid Concentrate for Solution for Infusion and 4 mg powder and solvent for solution for infusion.* 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Solutions, Sheet, Data, Zealand, Concentrate, Infusion, New zealand data sheet, Concentrate for solution for infusion, For solution for infusion
NORADRENALINE NOREPINEPHRINE 1 MG ML …
www.mhra.gov.ukMHRA PAR; NORADRENALINE (NOREPINEPHRINE) 1 MG / ML CONCENTRATE FOR SOLUTION FOR INFUSION, PL 31980/0001 2 Lay summary The Medicines and Healthcare products Regulatory Agency (MHRA) granted
Solutions, Concentrate, Infusion, Noradrenaline norepinephrine 1 mg ml, Noradrenaline, Norepinephrine, 1 mg ml concentrate for solution for infusion
VINORELBINE 10MG/ML CONCENTRATE FOR …
www.mhra.gov.ukMHRA-UKPAR – Vinorelbine 10mg/ml concentrate for solution for infusion PL 33410/0041 -2 - VINORELBINE 10MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
Solutions, Concentrate, Infusion, Concentrate for solution for infusion, Vinorelbine, Concentrate for
MATERIAL SAFETY DATA SHEET - pfizer.com
www.pfizer.com1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Material Name: Alprostadil Concentrate for Solution for Infusion Trade Name: Prostin VR Pediatric Sterile Solution; Prostivas
Solutions, Pfizer, Concentrate, Infusion, Concentrate for solution for infusion
Defined Daily Doses Pharmacological Dispensing …
www.who.intAminophylline Aminophylline 23.973mg/ml Solution for injection 600mg Xanthine - Bronchodilator R03DA05 PoM Cordarone® Scored tablet Amiodarone® Cardilor 200 Cordarone® 150mg Solution for injection